Literature DB >> 12939325

An experimental model of rhegmatogenous retinal detachment: surgical results and glial cell response.

Timothy L Jackson1, Jost Hillenkamp, Tom H Williamson, Kathleen W Clarke, Adel I Almubarak, John Marshall.   

Abstract

PURPOSE: To modify existing experimental models to simulate the typical clinical presentation of human rhegmatogenous retinal detachment (RRD), namely an RD caused by a retinal break, in a phakic eye, with a posterior vitreous detachment (PVD); to model RRD in a species that is anatomically similar to humans; and to characterize the glial cell response to RRD.
METHODS: Mixed-breed pigs underwent vitrectomy, PVD, subretinal injection of viscoelastic, and creation of a break at the apex of the RD. The crystalline lens was not removed. Follow-up was for 0, 1, and 7 days. Tissue was processed for light and electron microscopy. The glial cell response was characterized using antibodies to glial fibrillary acidic protein (GFAP).
RESULTS: Of 11 RRDs created in seven pigs, 10 increased in size and 1 decreased. Light and electron microscopy demonstrated typical features of RD. There was constitutive expression of GFAP in astrocytes and Müller cells with increased immunoreactivity from day 1.
CONCLUSIONS: This study provided a model of RRD that simulates the typical clinical presentation in humans. It used techniques that most vitreoretinal surgeons are familiar with, and an animal that is widely available and anatomically similar to humans. Anatomic success was high, and the glial cell response established comparability with other species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939325     DOI: 10.1167/iovs.02-1264

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  Experimental vitreoretinal surgery in porcine eyes.

Authors:  Claude Boscher; Didier Schmidt-Morand; Delphine Holopherne; Olivier Gauthier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-06       Impact factor: 3.117

2.  Anesthesia considerations in experimental vitreo retinal surgery in porcine eyes.

Authors:  Irene Sanchez; Raul Martin; Maria Plata-Cordero
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

3.  In vitro biomechanical modulation--retinal detachment in a box.

Authors:  Fredrik Ghosh; Karin Arnér; Linnéa Taylor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-12       Impact factor: 3.117

4.  Retreatment of full-thickness macular hole: predictive value of optical coherence tomography.

Authors:  Jost Hillenkamp; Jürgen Kraus; Carsten Framme; Timothy L Jackson; Johann Roider; Veit-Peter Gabel; Helmut G Sachs
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

5.  The effect of subretinal viscoelastics on the porcine retinal function.

Authors:  Nina Fischer Sørensen; Rasmus Ejstrup; Thøger Frøsig Svahn; Birgit Sander; Jens Kiilgaard; Morten la Cour
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

6.  Changes in membrane conductance play a pathogenic role in osmotic glial cell swelling in detached retinas.

Authors:  Antje Wurm; Thomas Pannicke; Ianors Iandiev; Eva Bühner; Uta-Carolin Pietsch; Andreas Reichenbach; Peter Wiedemann; Susann Uhlmann; Andreas Bringmann
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

7.  Upregulation of Semaphorin 3A and the associated biochemical and cellular events in a rat model of retinal detachment.

Authors:  Olga Klebanov; Anat Nitzan; Dorit Raz; Ari Barzilai; Arieh S Solomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-25       Impact factor: 3.117

8.  An experimental rabbit model of rhegmatogenous retinal detachment.

Authors:  Qing Xiao; Shuiqing Zeng; Yukai Huang; Jing Wang; Shaohua Li; Ying Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

9.  Long-term neuroretinal full-thickness transplants in a large animal model of severe retinitis pigmentosa.

Authors:  Fredrik Ghosh; Karl Engelsberg; Robert V English; Robert M Petters
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-27       Impact factor: 3.535

10.  Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina.

Authors:  I Fernandez-Bueno; M T Garcia-Gutierrez; G K Srivastava; M J Gayoso; J M Gonzalo-Orden; J C Pastor
Journal:  Mol Vis       Date:  2013-04-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.